(R)-2-amino-3-(1-benzyl-1H-imidazol-4-yl)-N-[3-methyl-4-(pyrrolidin-1-yl-carbonyl)-phenyl]-propionamide → HCID 178428662, 화합물

반응식

[NH2:1][C@H:2]([CH2:20][C:21]1[N:22]=[CH:23][N:24](CC2C=CC=CC=2)[CH:25]=1)[C:3]([NH:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]([N:14]2[CH2:18][CH2:17][CH2:16][CH2:15]2)=[O:13])=[C:8]([CH3:19])[CH:7]=1)=[O:4].[H][H]>C(O)(=O)C.[OH-].[OH-].[Pd+2]>[NH2:1][C@H:2]([CH2:20][C:21]1[N:22]=[CH:23][NH:24][CH:25]=1)[C:3]([NH:5][C:6]1[CH:11]=[CH:10][C:9]([C:12]([N:14]2[CH2:15][CH2:16][CH2:17][CH2:18]2)=[O:13])=[C:8]([CH3:19])[CH:7]=1)=[O:4]

참가 물질

실험 절차

350.0 mg (0.81 mmol) (R)-2-amino-3-(1-benzyl-1H-imidazol-4-yl)-N-[3-methyl-4-(pyrrolidin-1-yl-carbonyl)-phenyl]-propionamide are dissolved in 10.0 ml acetic acid and combined with 150.0 mg Pd(OH)2. The mixture is hydrogenated in a Parr apparatus at ambient temperature at 3 bar hydrogen pressure for eight hours. Then the catalyst is filtered off and the filtrate is evaporated down i. vac.